Table 2:

In-hospital, short-term and intermediate-term outcomes with endocarditis after TAVR

Variable	Overall N=1,868	Early endocarditis N=1221	Late endocarditis N=647	P value
Blood transfusion	262(14.0)	181(14.8)	81(12.5)	0.2
New pacemaker	-	24(2.0)	-	0.5
Surgical intervention
AV surgery	-	25(2.1)	-	0.3
Removal of PPM	80(4.3)	58(4.8)	22(3.4)	0.2
Acute kidney injury	620(33.2)	398(32.6)	222(34.3)	0.5
Cardiogenic shock	-	16(1.3)	-	0.5
Requiring ICU admission	672(36.0)	452(37.0)	220(34.0)	0.2
Length of ICU stay, days Median (IQR)	5 (3–9)	5 (2–9)	5.5 (3–10)	0.3
Length of stay, days Median (IQR)	8 (5–13)	8 (5–13)	8 (5–13)	0.2
Discharge disposition
Home	249(13.3)	179(14.7)	70(10.8)	0.01
Skilled nursing facility	590(31.6)	366(30.0)	224(34.6)
Home health care	380(20.4)	267(21.9)	113(17.5)
Hospice	75(4.1)	42(3.5)	33(5.1)
Long acute care facility	59(3.2)	41(3.4)	18(2.8)
In-hospital stroke	39(2.1)	28(2.3)	11(1.7)	0.4
In-hospital Intracranial hemorrhage	-	11(0.9)	-	0.9
30-day heart failure	125(6.7)	80(6.6)	45(7.0)	0.7
30-day stroke	71(3.8)	49(4.0)	22(3.4)	0.5
30-day mortality	345(18.5)	213(17.4)	132(20.4)	0.1
1-year mortality	851(45.6)	525(43.0)	326(50.4)	0.002

Values are presented as N (%) or Median (interquartile range)

Cells with N≤10, or cells that would reveal N<10 by calculation were suppressed with (−)